SKI Market

A+| A| A-|

Indian Indices

Sensex

76,395.87 195.19
( 0.26%)

Global Indices

Nasdaq

51,704.04 -29.67
(-0.06%)

Dow Jones

7,389.07 -104.72
(-1.40%)

Hang Seng

70,132.76 -2,221.20
(-3.07%)

Nikkei 225

10,454.55 16.70
(0.16%)

Forex

USD-INR

94.32 -0.07
(-0.07%)

EUR-INR

108.15 -0.25
(-0.23%)

GBP-INR

124.70 -0.38
(-0.31%)

JPY-INR

0.58 0.00
(-0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

423.3622252

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

33.63

115772.31

EPS(TTM)

Face Value()

Div & Yield %

42.61

0.91

Back

U. H. Zaveri standalone net profit declines 50.00% in the December 2025 quarter

Feb 13,2026

Net profit of U. H. Zaveri declined 50.00% to Rs 0.01 crore in the quarter ended December 2025 as against Rs 0.02 crore during the previous quarter ended December 2024. Sales rose 17.67% to Rs 18.25 crore in the quarter ended December 2025 as against Rs 15.51 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	18.25	15.51	18
OPM %	0.05	0.26	-
PBDT	0.01	0.04	-75
PBT	0.01	0.03	-67
NP	0.01	0.02	-50

76,395.87 195.19 ( 0.26%)

51,704.04 -29.67 (-0.06%)

7,389.07 -104.72 (-1.40%)

70,132.76 -2,221.20 (-3.07%)

10,454.55 16.70 (0.16%)

94.32 -0.07 (-0.07%)

108.15 -0.25 (-0.23%)

124.70 -0.38 (-0.31%)

0.58 0.00 (-0.32%)